PTGX Protagonist Therapeutics Inc.

Note: We have detected that our data provider shows 0 for short interest. Please manually confirm and if different, disregard the short data and short pain data below.

$6.84 -0.73%

107,713 Shares Traded
119,794 Average Volume (last 30 days)

as of December 17, 2018 EST IEX Real-Time Price

Click Here to Short Float History Versus Price & Peer Short Floats

Free Newsletter Sign Up


Protagonist Therapeutics Initiates Phase 1 Trial of Oral, Gut-Restricted, Alpha-4-Beta-7 Integrin Antagonist PN-10943 (PR Newswire)

Short Pain Metrics

Approximate Amount of Money Shorts Have Lost on the Day: $0
If Intiated on the First, Shorts Have Realized a Year to Date Return of:67.66%
If Intiated One Month Ago, Shorts Have Realized a Return of:13.09%
If Initiated Five Days ago, Shorts Have Realized a Return of:-1.94%
Peer Rising Stocks Near Real Time Screener
*Please note the actual returns of shorts could be different as they started from different points.

Daily Indicators

Daily Short Pain Indicator [i] - Always Use Fundamentals on EverythingNeutral
200 Day Moving Average Indicator Bearish
50 Day Moving Average Indicator Bearish
52 Week High/Low Indicator Neutral

Short Stats

Short Percent to Float 0%
Short Interest0
Float23.72 million
Short Ratio0
Market Cap$165.43 million
Market Maker ActivityDaily Short Volume

Smart Money Sentiment

Institutional Ownership (Top 15 Funds) 103.2%
Insider Percent2.2%

Earnings Stats

PE Ratio -5.26
Dividend Yield 0%

Earnings History For PTGX

Earnings DateQuarterConsensus EPSActual EPSEPS Surprise
2018-11-06 Q3 2018-0.4 (2 Estimates) -0.380.02
2018-08-07 Q2 2018-0.3 (2 Estimates) -0.41-0.11
2018-05-09 Q1 2018-0.24 (2 Estimates) -0.36-0.12
2018-03-07 AMCQ4 2017-0.36 (1 Estimates) -0.150.21


200 Day Moving Average $9.21
50 Day Moving Average $8.04
52 Week High $23.97
52 Week Low $5.49

Back to the Top

Data provided for free by IEX. Questions? Read the FAQ